Mechanisms and etiologies of thrombocytopenia in the intensive care unit: impact of extensive investigations. (abre nova janela)

Antier N, Quenot JP, Doise JM, Noel R, Demaistre E, Devilliers H

Fonte‎: Ann Intensive Care 2014;4:24.

Indexado‎: PubMed 25593741

DOI‎: 10.1186/s13613-014-0024-x

https://www.ncbi.nlm.nih.gov/pubmed/25593741 (abre nova janela)

Drugs affecting coagulation. (abre nova janela)

Appadu B

Fonte‎: Anaesth Intensive Care Med 2010;11(6):247-53.

Indexado‎: EMBASE 2010500347

DOI‎: 10.1016/j.mpaic.2010.03.004

https://dx.doi.org/10.1016/j.mpaic.2010.03.004 (abre nova janela)

Approach to the diagnosis and management of drug-induced immune thrombocytopenia. (abre nova janela)

Arnold DM, Nazi I, Warkentin TE, Smith JW, Toltl LJ, George JN, Kelton JG

Fonte‎: Transfus Med Rev 2013;27(3):137-45.

Indexado‎: PubMed 23845922

DOI‎: 10.1016/j.tmrv.2013.05.005

https://www.ncbi.nlm.nih.gov/pubmed/23845922 (abre nova janela)

Drug-induced immune thrombocytopenia. (abre nova janela)

Aster RH, Bougie DW

Fonte‎: N Engl J Med 2007;357(6):580-7.

Indexado‎: PubMed 17687133

DOI‎: 10.1056/NEJMra066469

https://www.ncbi.nlm.nih.gov/pubmed/17687133 (abre nova janela)

Thrombocytopenia in the intensive care unit patient. (abre nova janela)

Greinacher A, Selleng K

Fonte‎: Hematology Am Soc Hematol Educ Program 2010;2010:135-43.

Indexado‎: PubMed 21239783

DOI‎: 10.1182/asheducation-2010.1.135

https://www.ncbi.nlm.nih.gov/pubmed/21239783 (abre nova janela)

Variability of findings in drug-induced immune haemolytic anaemia: experience over 20 years in a single centre. (abre nova janela)

Mayer B, Bartolmäs T, Yürek S, Salama A

Fonte‎: Transfus Med Hemother 2015;42(5):333-9.

Indexado‎: PubMed 26696803

DOI‎: 10.1159/000440673

https://www.ncbi.nlm.nih.gov/pubmed/26696803 (abre nova janela)

Anemia, bleeding, and blood transfusion in the intensive care unit: causes, risks, costs, and new strategies. (abre nova janela)

McEvoy MT, Shander A

Fonte‎: Am J Crit Care 2013;22(6 Suppl):eS1-13.

Indexado‎: PubMed 24186829

DOI‎: 10.4037/ajcc2013729

https://www.ncbi.nlm.nih.gov/pubmed/24186829 (abre nova janela)

Drug-induced thrombocytopenia in critically ill patients. (abre nova janela)

Priziola JL, Smythe MA, Dager WE

Fonte‎: Crit Care Med 2010;38(6 Suppl):S145-54.

Indexado‎: PubMed 20502168

DOI‎: 10.1097/CCM.0b013e3181de0b88

https://www.ncbi.nlm.nih.gov/pubmed/20502168 (abre nova janela)

Recurrent acute thrombocytopenia in the hospitalized patient: sepsis, DIC, HIT, or antibiotic-induced thrombocytopenia. (abre nova janela)

Rousan TA, Aldoss IT, Cowley BD Jr, Curtis BR, Bougie DW, Aster RH, George JN

Fonte‎: Am J Hematol 2010;85(1):71-4.

Indexado‎: PubMed 19802882

DOI‎: 10.1002/ajh.21536

https://www.ncbi.nlm.nih.gov/pubmed/19802882 (abre nova janela)

Drugs that affect platelet function. (abre nova janela)

Scharf RE

Fonte‎: Semin Thromb Hemost 2012;38(8):865-83.

Indexado‎: PubMed 23111864

DOI‎: 10.1055/s-0032-1328881

https://www.ncbi.nlm.nih.gov/pubmed/23111864 (abre nova janela)

Drug-induced anemia and other red cell disorders: a guide in the age of polypharmacy. (abre nova janela)

Shander A, Javidroozi M, Ashton ME.

Fonte‎: Curr Clin Pharmacol 2011;6(4):295-303.

Indexado‎: PubMed 22082327

https://www.ncbi.nlm.nih.gov/pubmed/22082327 (abre nova janela)

Vancomycin-induced immune thrombocytopenia. (abre nova janela)

Von Drygalski A, Curtis BR, Bougie DW, McFarland JG, Ahl S, Limbu I, Baker KR, Aster RH

Fonte‎: N Engl J Med 2007;356(9):904-10.

Indexado‎: PubMed 17329697

DOI‎: 10.1056/NEJMoa065066

https://www.ncbi.nlm.nih.gov/pubmed/17329697 (abre nova janela)

Evaluation and management of drug-induced thrombocytopenia in the acutely ill patient. (abre nova janela)

Wazny LD, Ariano RE

Fonte‎: Pharmacotherapy 2000;20(3):292-307.

Indexado‎: PubMed 10730685

DOI‎: 10.1592/phco.20.4.292.34883

https://www.ncbi.nlm.nih.gov/pubmed/10730685 (abre nova janela)